Ablating Barrett's metaplastic epithelium: Are the techniques ready for clinical use?

Gut

Volumn 55, Issue 9, 2006, Pages 1222-1223

  Bergman, J J G H M ^a   Fockens, P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; CANCER RISK; CLINICAL FEATURE; CLINICAL TRIAL; ELECTROCOAGULATION; ENDOSCOPY; HEART ARRHYTHMIA; HUMAN; INTERMETHOD COMPARISON; LASER COAGULATION; NOTE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SCREENING; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT PLANNING;

BARRETT ESOPHAGUS; ELECTROCOAGULATION; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; HUMANS; LASER COAGULATION; PRECANCEROUS CONDITIONS;

EID: 33747780471     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.092106     Document Type: Note

References (19)

1. Shaheen NJ, Green B, Medapalli RK, et al. The perception of cancer risk in patients with prevalent Barrett's esophagus enrolled in an endoscopic surveillance program. Gastroenterology 2005;129:429-36.
2. Shaheen NJ, Dulai GS, Ascher B, et al. Effect of a new diagnosis of Barrett's esophagus on insurance status. Am J Gastroenterol 2005;100:577-80.
3. Oelschlager BK, Barreca M, Chang L, et al. Clinical and pathologic response or Barrett's esophagus to laparoscopic antireflux surgery. Ann Surg 2003;238:458-64.
4. Richter JE. Let the patient beware: the evolving truth about laparoscopic antireflux surgery. Am J Med 2003;114:71-3.
5. Ouatu-Lascar R, Fitzgerald RC, Triadafilopoulos G. Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. Gastroenterology 1999;117:327-35.
6. El Serag HB, Aguirre W, Davis S, et al. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus. Am J Gastroenterol 2004;99:1877-83.
7. Hillman LC, Chiragakis L, Shadbolt B, et al. Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus. Med J Aust 2004;180:387-91.
8. Sampliner RE. Reversal of Barrett's esophagus with electrocoagulation and laser. J Gastrointest Surg 2000;4:122-3.
9. Dulai GS, Jensen DM, Cortina G, et al. Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrointest Endosc 2005;61:232-40.
10. Ackroyd R, Tam W, Schoeman M, et al. Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett's esophagus after antireflux surgery. Gastrointest Endosc 2004;59:1-7.
11. Ganz RA, Utley DS, Stern R, et al. Complete ablation of porcine esophageal epithelium using a balloon-based bipolar electrode. Gastrointest Endosc 2004;59:AB250.
12. Johnston MH, Eastone JA, Horwhat JD, et al. Cryoablation of Barrett's esophagus: a pilot study. Gastrointest Endosc 2005;62:842-8.
13. Hage M, Siersema PD, van Dekken M, et al. 5-Aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial. Gut 2004;53:785-90.
14. Sharma P, Wani S, Weston AP, et al. A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results. Gut 2006;55:1233-9.
15. Shand A, Dallal H, Palmer K, et al. Adenocarcinoma arising in columnar lined oesophagus following treatment with argon plasma coagulation. Gut 2001;48:580-1.
16. Van Laethem JL, Peny MO, Salmon I, et al. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. Gut 2000;46:574-7.
17. Weston AP, Sharma P, Mathur S, et al. Risk stratification of Barrett's esophagus: updated prospective multivariate analysis. Am J Gastroenterol 2004;99:1657-66.
18. Reid BJ, Prevo U, Galipeau PC, et al. Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am J Gastroenterol 2001;96:2839-48.
19. Skacel M, Petras RE, Gramlich TL, et al. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression. Am J Gastroenterol 2000;95:3383-7.